116 related articles for article (PubMed ID: 1020445)
1. [Role of physiologically active substances in the pathogenesis and therapy of atherosclerosis].
Klimov AN
Vestn Akad Med Nauk SSSR; 1976; (9):48-50. PubMed ID: 1020445
[No Abstract] [Full Text] [Related]
2. Experimental investigation of hypolipidemic and anti-atherosclerotic drugs with different mechanism of action.
Klimov AN; Ryzhenkov VE; Petrova LA; Polyakova ED
Adv Exp Med Biol; 1977; 82():477-82. PubMed ID: 920403
[No Abstract] [Full Text] [Related]
3. [Effect of ethirazol and parmidine ofn the development of experimental atherosclerosis in rabbits].
Ryzhenkov VE; Tararak EM; Khechinashvili GG; Mosina IV
Biull Eksp Biol Med; 1976 May; 81(5):558-9. PubMed ID: 947379
[TBL] [Abstract][Full Text] [Related]
4. [Effect of chonsuride and chondroitin sulfate A on lipid metabolism and experimental atherosclerosis in rabbits].
Ryzhenkov VE; Khechinashvili GG; Mosina IV
Patol Fiziol Eksp Ter; 1977; (5):79-81. PubMed ID: 600563
[No Abstract] [Full Text] [Related]
5. Electron microscope study concerning the influence of chondroitin sulphate to an experimental atherosclerosis in rabbits.
Hagel EU
Mater Med Pol; 1976; 8(3):273-84. PubMed ID: 1011869
[No Abstract] [Full Text] [Related]
6. Antiatherogenic effect of pyridinolcarbamate (prodectin). Experimental study.
Orbetzova V; Jurukova Z; Orbetzova M
Artery; 1980; 8(6):560-9. PubMed ID: 7259535
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of pyridinolcarbamate effect on patients with obliterating atherosclerosis (author's transl)].
Roztocil K; Oliva I; Linhart J; Prerovský I; Modr Z
Cas Lek Cesk; 1976 Aug; 115(33-34):1051-5. PubMed ID: 975177
[No Abstract] [Full Text] [Related]
8. [Protective effect of carbamate pyridinol on experimental atheroma in the rat].
Bouissou H; Julian M; Pieraggi MT
Pathol Biol (Paris); 1974 Oct; 22(8):713-20. PubMed ID: 4614172
[No Abstract] [Full Text] [Related]
9. [Prodectin treatment of partial hearing loss as a result of atherosclerosis].
Smirnova NA; Timakov VA; Mikushkin MK
Vestn Otorinolaringol; 1982; (6):53-6. PubMed ID: 7179649
[No Abstract] [Full Text] [Related]
10. Pyridinolcarbamate and experimental atherosclerosis. Correlation of hypocholesterolemic and antiatherogenic effects.
Albert EN; Kassira WN; Muesing R; Vahouny GV
Atherosclerosis; 1978 Oct; 31(2):205-15. PubMed ID: 728238
[TBL] [Abstract][Full Text] [Related]
11. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
Pola P
Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
[No Abstract] [Full Text] [Related]
12. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
Pola P
J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
[No Abstract] [Full Text] [Related]
13. [Pyridinolcarbamate treatment of ischemic heart disease].
Kuz'ko NV
Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
[No Abstract] [Full Text] [Related]
14. [Mechanism of action of the antikinin preparation pyridinolcarbamate on the development of experimental tuberculosis].
Makinskiĭ AI; Solov'eva IP; Braude VI
Probl Tuberk; 1984 May; (5):60-5. PubMed ID: 6739480
[No Abstract] [Full Text] [Related]
15. The effects of piridinol carbamate on hypercholesteremia and aortal damage produced by 5 days' application of Altman's diet to the rat.
Iwanowska J; Starzyński S; Kalinowska A
Pol J Pharmacol Pharm; 1980; 32(3):333-41. PubMed ID: 6974352
[TBL] [Abstract][Full Text] [Related]
16. Attempts to delay progression in occlusive atherosclerosis.
Terry EN; Rouen LR; Clasuss RH; Katz MC; Redisch W
Ann N Y Acad Sci; 1976; 275():379-85. PubMed ID: 1070279
[No Abstract] [Full Text] [Related]
17. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
Valiensi M; Riboli E; Lombardi M
Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654
[No Abstract] [Full Text] [Related]
18. [Effect of parmidin on the course of tuberculosis under isoniazid therapy].
Solov'eva IP; Makinskiĭ AI
Vrach Delo; 1984 Sep; (9):70-3. PubMed ID: 6390963
[No Abstract] [Full Text] [Related]
19. Clinical and laboratory examinations with Prodectin.
Bédi J; Kosztovics A; Pálos LA
Ther Hung; 1976; 24(3):91-7. PubMed ID: 1013926
[No Abstract] [Full Text] [Related]
20. Prevention of experimental atherosclerosis with pyridinolcarbamate.
Wu CC; Huang TS; Hsu CJ
Am Heart J; 1969 May; 77(5):657-67. PubMed ID: 5778056
[No Abstract] [Full Text] [Related]
[Next] [New Search]
